Esperion Therapeutics Balance Sheet - Quarterly (NASDAQ:ESPR)

Add to My Stocks
$33.19 $0.22 (0.67%) ESPR stock closing price May 24, 2017 (Closing)

The financial analysis of a company involves interpreting the income statement, balance sheet and cash flow statements of the company to draw insights like we've done in our Esperion Therapeutics stock analysis. Financial strength can be guaged by performing Esperion Therapeutics stock analysis and by analyzing the balance sheet. Good quarterly results indicate a company's strong financial performance. Its important to check all financial statements including the balance sheet. Esperion Therapeutics had a long term debt of $0.59M at the end of 2017-Q1. View Esperion Therapeutics quarterly results to get the balance sheet details for the latest & last 40 quarters data..

show more
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec. 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4
Marketable Securities162.02M173.41M162.96M158.41M157.26M134.92M134.77M94.99M69.46M20.8M
Raw Materials----------
Work In Progress----------
Finished Goods----------
Notes Receivable----------
Other Current Assets6.13M1.99M3.36M1.91M2.58M2.13M3.24M0.93M1.71M0.92M
Esperion Therapeutics Total Current Assets
Property Plant & Equipment-1.28M---1.16M---1.18M
Accumulated Depreciation-0.6M---0.35M---0.4M
Esperion Therapeutics Net Property Plant & Equipment
Investment & Advances25.92M30.9M49.64M67.63M88.18M80.31M86.77M89.5M44.61M35.74M
Other Non-Current Assets----------
Deferred Charges----------
Deposits & Other Assets----------
Esperion Therapeutics Total Assets
Notes Payable----------
Accounts Payable11.64M4.59M1.78M1.56M1.54M0.7M1.97M3.3M2.89M2.04M
Current Portion Long-Term Debt1.74M1.7M1.68M1.65M1.62M1.6M1.57M1.42M1.03M0.63M
Current Portion Capital Leases----------
Accrued Expenses8.23M9.28M4.69M4.41M2.82M3.31M3.27M2.29M3.01M2.81M
Income Taxes Payable----------
Other Current Liabilities----------
Esperion Therapeutics Total Current Liabilities
Deferred Taxes/Income----------
Convertible Debt----------
Long-Term Debt0.59M1.02M1.45M1.87M2.28M2.68M3.08M3.47M3.85M4.29M
Non-Current Capital Leases----------
Other Long-Term Liabilities----------
Esperion Therapeutics Total Liabilities
Minority Interest----------
Preferred Stock----------
Common Stock Net0.02M0.02M0.02M0.02M0.02M0.02M0.02M0.02M0.02M0.02M
Capital Surplus462.47M457.95M454.37M450.66M446.52M441.94M437.54M433.79M430.34M238.03M
Retained Earnings-269.84M-229.2M-200.24M-182.84M-168.8M-154.22M-141.1M-128.29M-115.9M-104.43M
Treasury Stock----------
Other Liabilities-0.23M-0.17M0.02M0.11M0.01M-0.48M0.01M-0.06M-0.03M-0.05M
Esperion Therapeutics Shareholders Equity
Esperion Therapeutics Total Liabilities & Shareholders Equity
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters
Get Balance sheet for another ticker

Looking at Esperion Therapeutics historical stock prices and the current Esperion Therapeutics stock price can tell you how the stock price has moved, whereas the Esperion Therapeutics PE ratio chart shows if its shares are overpriced in comparison to peers. The important things to look for in a balance sheet are:
  • Assets: An asset is a resource that a corporation like Esperion Therapeutics owns and has monetary significance. ESPR assets decreased from $245.21M in 2016-Q4 to $214.61M in 2017-Q1 . Assets can be of two types: fixed assets like real estate, plant and machinery; and current assets which includes cash, accounts receivable etc. Tech stocks typically don't have too many assets.
  • Liabilities: This item on the balance sheet implies the firm's, in this case Esperion Therapeutics's, legal obligations including loans, accounts payable, deferred revenue, accrued expenses and mortgages. The total liabilities for ESPR stock stand at $22.19M.